Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Kanyos Bio
Kanyos Bio
Promising autoimmune biotech gets $40 million as celiac drug is pushed to clinic
Promising autoimmune biotech gets $40 million as celiac drug is pushed to clinic
Endpoints
celiac disease
autoimmune disease
Anokion
Kanyos Bio
Kan-101
Flag link:
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Astellas wagers $760M to launch an autoimmune biotech in Cambridge, MA
Fierce Biotech
Astellas
autoimmune disease
Kanyos Bio
Anokion
Flag link:
